1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3.
Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7.
Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
4.1.
Brand Awareness
4.2.
Impact of Radiomics on Different Therapeutic Areas
4.3.
Barriers to Adoption of Radiomics
5. Clinical Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Application
5.7. Breakdown of
Pipeline, By Region
5.8.
Clinical Trials Heat Map
6. Patents Analysis
7. Global Radiomics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography
(CT), Positron-Emission-Tomography (PET), Others)
7.2.2.
By Image Type (2D v/s 3D)
7.2.3.
By Technology (Engineered Features v/s Deep Learning)
7.2.4.
By Application (Nuclear Medicine, Medical Imaging,
Precision Medicine, Oncology, Others)
7.2.5. By
Region
7.2.6.
By Company (2022)
7.3.
Product Market Map
7.3.1.
By Modality
7.3.2.
By Image Type
7.3.3.
By Technology
7.3.4.
By Application
7.3.5.
By Region
8. North America Radiomics
Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By
Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography
(PET), Others)
8.2.2. By
Image Type (2D v/s 3D)
8.2.3. By
Technology (Engineered Features v/s Deep Learning)
8.2.4. By
Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology,
Others)
8.2.5. By Country
8.3.
North America: Country Analysis
8.3.1.
United States Radiomics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Modality
8.3.1.2.2.
By Image Type
8.3.1.2.3.
By Technology
8.3.1.2.4.
By Application
8.3.2.
Mexico Radiomics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Modality
8.3.2.2.2.
By Image Type
8.3.2.2.3.
By Technology
8.3.2.2.4.
By Application
8.3.3.
Canada Radiomics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Modality
8.3.3.2.2.
By Image Type
8.3.3.2.3.
By Technology
8.3.3.2.4.
By Application
9. Europe Radiomics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography
(CT), Positron-Emission-Tomography (PET), Others)
9.2.2.
By Image Type (2D v/s 3D)
9.2.3.
By Technology (Engineered Features v/s Deep Learning)
9.2.4.
By Application (Nuclear Medicine, Medical Imaging,
Precision Medicine, Oncology, Others)
9.2.5.
By Country
9.3.
Europe: Country Analysis
9.3.1.
France Radiomics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Modality
9.3.1.2.2.
By Image Type
9.3.1.2.3.
By Technology
9.3.1.2.4.
By Application
9.3.2.
Germany Radiomics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Modality
9.3.2.2.2.
By Image Type
9.3.2.2.3.
By Technology
9.3.2.2.4.
By Application
9.3.3.
United Kingdom Radiomics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Modality
9.3.3.2.2.
By Image Type
9.3.3.2.3.
By Technology
9.3.3.2.4.
By Application
9.3.4.
Italy Radiomics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Modality
9.3.4.2.2.
By Image Type
9.3.4.2.3.
By Technology
9.3.4.2.4.
By Application
9.3.5.
Spain Radiomics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Modality
9.3.5.2.2.
By Image Type
9.3.5.2.3.
By Technology
9.3.5.2.4.
By Application
10. Asia-Pacific Radiomics
Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography
(CT), Positron-Emission-Tomography (PET), Others)
10.2.2.
By Image Type (2D v/s 3D)
10.2.3.
By Technology (Engineered Features v/s Deep Learning)
10.2.4.
By Application (Nuclear Medicine, Medical Imaging,
Precision Medicine, Oncology, Others)
10.2.5.
By Country
10.3.
Asia-Pacific: Country Analysis
10.3.1.
China Radiomics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Modality
10.3.1.2.2.
By Image Type
10.3.1.2.3.
By Technology
10.3.1.2.4.
By Application
10.3.2.
India Radiomics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Modality
10.3.2.2.2.
By Image Type
10.3.2.2.3.
By Technology
10.3.2.2.4.
By Application
10.3.3.
Japan Radiomics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Modality
10.3.3.2.2.
By Image Type
10.3.3.2.3.
By Technology
10.3.3.2.4.
By Application
10.3.4.
South Korea Radiomics Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Modality
10.3.4.2.2.
By Image Type
10.3.4.2.3.
By Technology
10.3.4.2.4.
By Application
10.3.5.
Australia Radiomics Market Outlook
10.3.5.1.
Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2.
Market Share & Forecast
10.3.5.2.1.
By Modality
10.3.5.2.2.
By Image Type
10.3.5.2.3.
By Technology
10.3.5.2.4.
By Application
11. South America Radiomics
Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography
(CT), Positron-Emission-Tomography (PET), Others)
11.2.2.
By Image Type (2D v/s 3D)
11.2.3.
By Technology (Engineered Features v/s Deep Learning)
11.2.4.
By Application (Nuclear Medicine, Medical Imaging,
Precision Medicine, Oncology, Others)
11.2.5.
By Country
11.3.
South America: Country Analysis
11.3.1.
Brazil Radiomics Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Modality
11.3.1.2.2.
By Image Type
11.3.1.2.3.
By Technology
11.3.1.2.4.
By Application
11.3.2.
Argentina Radiomics Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Modality
11.3.2.2.2.
By Image Type
11.3.2.2.3.
By Technology
11.3.2.2.4.
By Application
11.3.3.
Colombia Radiomics Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Modality
11.3.3.2.2.
By Image Type
11.3.3.2.3.
By Technology
11.3.3.2.4.
By Application
12. Middle East and
Africa Radiomics Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1.
By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography
(CT), Positron-Emission-Tomography (PET), Others)
12.2.2.
By Image Type (2D v/s 3D)
12.2.3.
By Technology (Engineered Features v/s Deep Learning)
12.2.4.
By Application (Nuclear Medicine, Medical Imaging,
Precision Medicine, Oncology, Others)
12.2.5.
By Country
12.3.
MEA: Country Analysis
12.3.1.
South Africa Radiomics Market Outlook
12.3.1.1.
Market Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2.
Market Share & Forecast
12.3.1.2.1.
By Modality
12.3.1.2.2.
By Image Type
12.3.1.2.3.
By Technology
12.3.1.2.4.
By Application
12.3.2.
Saudi Arabia Radiomics Market Outlook
12.3.2.1.
Market Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2.
Market Share & Forecast
12.3.2.2.1.
By Modality
12.3.2.2.2.
By Image Type
12.3.2.2.3.
By Technology
12.3.2.2.4.
By Application
12.3.3.
UAE Radiomics Market Outlook
12.3.3.1.
Market Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2.
Market Share & Forecast
12.3.3.2.1.
By Modality
12.3.3.2.2.
By Image Type
12.3.3.2.3.
By Technology
12.3.3.2.4.
By Application
12.3.4.
Kuwait Radiomics Market Outlook
12.3.4.1.
Market Size & Forecast
12.3.4.1.1.
By Value
12.3.4.2.
Market Share & Forecast
12.3.4.2.1.
By Modality
12.3.4.2.2.
By Image Type
12.3.4.2.3.
By Technology
12.3.4.2.4.
By Application
13. Market Dynamics
13.1.
Drivers
13.1.1.
Integration of Artificial Intelligence in Medical Imaging
13.1.2.
Increased Reliance Radiology for Medical Diagnosis
13.1.3.
Growing Population with Cancer and Cardiovascular Disorders
13.2.
Challenges
13.2.1.
Imaging Protocols Not Standardized/Technological Restraints
13.2.2.
Budget Cuts of Hospitals
13.2.3.
Lack of Validation and Risk of False-Positive Results
14. Market Trends &
Developments
14.1.
Growing Research and Investment Activities
14.2.
Opportunities in Emerging Countries
14.3.
Adoption of Better Healthcare Facilities
15. Competitive
Landscape
15.1.
Business Overview
15.2.
Company Snapshot
15.3.
Products & Services
15.4.
Financials (As Reported)
15.5.
Recent Developments
15.6.
SWOT Analysis
15.6.1.
Radiomics.io (Computational
Imaging & Bioinformatics Lab)
15.6.2.
Radiomics Bio
(Belgium)
15.6.3.
Health Innovation
Ventures (HIV)
15.6.4.
Sophia Genetics SA
15.6.5.
HealthMyne Inc
15.6.6.
Oncoradiomics
15.6.7. ptTheragnostic BV
16. Strategic Recommendations